Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth. Br J Cancer. 2013 Feb 05; 108(2):342-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.